BioAlliance Pharma: Presentation of Livatag Survival Results at the International Liver Cancer Congress in Hong Kong
PARIS–(BUSINESS WIRE)–Sep 5, 2011 – Regulatory News:BioAlliance Pharma SA (Paris:BIO), a company dedicated to specialtyand orphan oncology products, today announces oral communication ofthe Phase II clinical trial results of its orphan…
September 7th, 2011
Posted in
Drug

